Hints and tips:
Related Special Reports
...Patents affected by the FTC action also included weight-loss drugs produced by AstraZeneca, and asthma and COPD inhalers produced by GSK and Teva Pharmaceuticals....
...“The USA and the EU must see each other as strategic partners rather than zero-sum competitors in raising global competitiveness and tackling global challenges,” he said....
...The leader of the pack was Teva Pharmaceuticals, whose market capitalisation reached $60bn in 2015. Teva now sits in the crosshairs of law enforcement....
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...“The FDA has not been inspecting facilities during Covid that much outside of the USA....
...Generics have been the métier of Teva rather than genetics. It is here that the story starts darkening....
...And on closer look, those block trades weren’t quite as war-profiteering as they might sound: These are trades in SolarEdge Technologies and Teva Pharmaceuticals....
...Pharmaceutical groups Teva and Allergan have agreed to pay a combined $6.5bn to settle claims related to their role in fuelling the US opioids crisis....
...The closure in April of a big US generics company Akorn Pharmaceuticals and Teva Pharmaceuticals’ decision last month to trim its generics portfolio highlight the extreme pressure the industry is under,...
...Initially, the framework will be used to assess the efforts of five companies: Cipla, Hikma, Sun Pharma, Teva and Viatris....
...Catalyst Pharma shares sank 34.62 per cent on Monday to $13.61 per share after rival pharmaceutical company Teva announced it sought authorisation from the US Food and Drug Administration to manufacture...
...The surge in sales will boost profits for the two private equity groups, Kelso and Juggernaut, that bought the branded version of the drug from pharmaceutical group Teva in 2017 for $675mn....
...Certainly, Team USA seemed to be thinking bigger and broader than its EU peers....
...A $5bn “sustainability-linked” bond sold by Teva Pharmaceutical Industries on Tuesday was the largest of its kind, but drew immediate questions from some investors about its environmental and social claims...
...Sandoz’s peers Teva and Viatris trade on an enterprise value-to-forward ebitda multiple of 6.4 times. If Sandoz was valued similarly, it would be worth just $15bn. But Sandoz deserves a higher rating....
...Teva declined to comment. Lumen and UltraTech did not respond to a request for comment. *This story has been amended to indicate that Teva is an Israel-based drugmaker....
...So I was talking to a company in Warwick the other day that makes super high-end automated manufacturing products for the pharmaceutical industry....
...“Pharmaceutical companies need to take seriously the prospect that the [commission] may instigate an inquiry into such practices.”...
...It exited its position in generic drugs maker Teva and sold more than 70 per cent of its remaining shares in AbbVie and Bristol-Myers Squibb....
...Teva is one of four pharmaceutical companies in the midst of an opioid trial in California and is accused of engaging in misleading marketing which played down the risks of opioid addiction....
...That might justify a steeper EV-to-forward ebitda multiple than the seven times commanded by quoted generics companies Teva and Viatris. The unit might fetch at least $15bn, according to Bernstein....
...The chief executive of Teva Pharmaceuticals said the major coronavirus vaccine makers declined his company’s offer to help manufacture the jab, despite Teva having production capacity ready to use....
...Already, in November, pharmaceutical company Teva has raised a record $5bn through a sustainability-linked bond....
...Its case against Endo, Teva, and Allergan is currently being tried in state court. The settlement payments to New York will begin this summer and continue over the next 17 years....
International Edition